What is CRIS's market cap?

$2.21M, based on the Nov 5 close of $0.91.

Does Curis pay a dividend?

No regular cash dividend has been paid in the last year.

How much of CRIS is sold short?

439.3K shares, 23.2% of float, as of Oct 15, 2026.

What sector is CRIS in?

Healthcare, in the Biotechnology industry.

NASDAQ · CRISHealthcareBiotechnology

Curis Inc (CRIS)

$0.9098−18.04%

Close Nov 5, 2026 · split-adjusted

Nov 5, 2026$0.91▼ 96.88% in range

Nov 4, 2025Low $0.38 · High $138.64Nov 5, 2026

What changed · written from our data

As of Nov 5, 2026

Curis closed at $0.91 on Nov 5, down 18.04%, 99.3% below its 52-week closing high. Volume of 10.5M shares was 0.93× its 20-day average (close to normal).

Split-adjusted performance: +23.5% over one month, -92.1% over six months, -96.9% over one year.

Short interest was 439.3K shares at the Oct 15 settlement, up 144.8% from the prior report (23.2% of float, 1.9 days to cover).

Market cap$2.2M2.4M shares

Revenue · quarter$0.00−100.0% YoY

Diluted EPS$-4.02—

P/E · TTM—P/S 0.5×

Net margin—

Dividend yieldNone

52-week range0.38 – 138.64−99.3% from high

Volume10.5M0.93× 20-day avg

Volatility · 60d139.7%Annualised

Short % of float23.2%2.0 days to cover

Net cash$5.1MCash $5.1M

Next earnings—Not scheduled

Split-adjusted performance

1W +65.9%1M +23.5%3M −77.4%6M −92.1%YTD −95.4%1Y −96.9%3Y −99.0%5Y −100.0%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Biotechnology

Percentile among 139 companies (100 = best)

6-month momentum1

Revenue growth6

Net margin—

Value (low P/E)—

Size2

Industry medians: 6-month return −24.1%, revenue growth +8.5%, net margin −226.4%, P/E 21.4×.

Short interest

Details →

Shares short439.3K+144.8% vs prior

Days to cover2.0Settled Oct 15

% of float23.2%

Short vol. 10d62.8%of daily volume

Closest peers by size in Biotechnology

Company	Price	Today	6M	Rev. growth	Net margin	P/E	Mkt cap
CRISCuris	$0.9098	−18.04%	−92.1%	−100.0%	—	—	$2.2M
SLXNSilexion Therapeutics	$0.1430	−6.84%	−97.2%	—	—	—	$2.1M	Compare
HLSQTessera Defense and Homeland Security	$0.1234	−14.31%	—	—	—	—	$2.5M	Compare
VIVSVivoSim Labs	$0.1418	−6.83%	−89.9%	−51.4%	−7433.3%	—	$1.9M	Compare
CLDICalidi Biotherapeutics	$0.6751	−7.51%	−80.5%	—	—	—	$1.7M	Compare
LIMNLiminatus Pharma	$2.64	−5.53%	−73.7%	—	—	—	$3.5M	Compare
PMCBPharmaCyte Biotech	$0.3740	−1.84%	−53.3%	—	—	—	$4.0M	Compare
CELZCreative Medical Technology Holdings	$0.6122	−6.09%	−73.3%	—	—	—	$4.6M	Compare
SNTISenti Biosciences Holdings	$0.1553	−12.06%	−84.2%	—	−75000.0%	—	$6.0M	Compare

News about Curis

All news →

Curis (CRIS) Q4 2025 Earnings Call TranscriptThe Motley Fool · Mar 19, 2026▲ Positive

Quick answers

What does Curis do?: Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others.
What is CRIS's market cap?: $2.21M, based on the Nov 5 close of $0.91.
Does Curis pay a dividend?: No regular cash dividend has been paid in the last year.
How much of CRIS is sold short?: 439.3K shares, 23.2% of float, as of Oct 15, 2026.
What sector is CRIS in?: Healthcare, in the Biotechnology industry.

About Curis

Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.

HQ: Lexington, MA24 employeesListed Aug 1, 2000curis.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology